SCHEMBL4882813

SCHEMBL4882813

COc1cc(OC)c(S(=O)(=O)N2CCCC(CO)C2)cc1-c1n[nH]cc1Oc1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.41
CYP19A1 P11511 2/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALOX5AP P20292 2/20 0.39
FEN1 P39748 2/20 0.39
POLB P06746 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 1/20 0.38
HTR2C P28335 1/20 0.38
HTT P42858 3/20 0.38
NPC1 O15118 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 2/20 0.37
TSHR P16473 2/20 0.37
MAPK1 P28482 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873453 0.88 CYP3A4 (0.41) ATMCYP3A4CYP2C19ALOX5APFEN1
SCHEMBL14197368 0.83 LMNA (0.37) ATMCYP19A1POLBSMN1; SMN2MAPT
SCHEMBL4883499 0.77 LMNA (0.37) MAPTNPSR1KMT2AALDH1A1MEN1
SCHEMBL1628573 0.77 CYP19A1 (0.41) ATMCYP19A1ALOX5APFEN1POLB
SCHEMBL4885629 0.76 TRPV4 (0.39) SMN1; SMN2KMT2ATSHRMEN1GAA
SCHEMBL4876500 0.74 MAPT (0.49) CYP3A4CYP2C19POLBSMN1; SMN2MAPT
SCHEMBL4881235 0.71 ALDH1A1 (0.41) POLBSMN1; SMN2MAPTKMT2AALDH1A1
SCHEMBL4884645 0.70 ALDH1A1 (0.46) POLBSMN1; SMN2NPC1ALDH1A1LMNA
SCHEMBL4881914 0.66 KMT2A (0.34) SMN1; SMN2MAPTHTTKMT2AALDH1A1
SCHEMBL4876502 0.65 CYP1A2 (0.41) ATMCYP3A4CYP2C19SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed
EP-1799649-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS Merck Patent GmbH (DE) 2007-06-27 EP disclosed
WO-2006039977-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P ATM 1398/4885CYP19A1 2452/4885CYP3A4 1583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.